Clinical Trials
7 trialsNCT05027425 2026-05-06
Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant
University of Cincinnati
Phase 2 Terminated
NCT05475613 2024-11-29
Downstaging Protocol Containing Immunotherapy for HCC Beyond the Milan Criteria Before Liver Transplantation
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2 Recruiting
NCT04898504 2024-11-07
EXCALIBUR1+2
Oslo University Hospital
Phase 2 Active not recruiting
NCT00294827 2023-11-07
Liver Transplantation and Metastatic Colo-rectal Cancer.
Oslo University Hospital
Phase 2 Unknown
NCT03803436 2023-03-16
COLT
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2 Unknown
NCT01151761 2016-07-29
Phase II SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver Transplantation
Stanford University
Phase 2 Terminated
NCT02202564 2014-07-29
Preliminary Results for the Double-dose Adenovirus-mediated Adjuvant Therapy Improving Outcome of Liver Transplantation in Patients With Advanced Hepatocellular Carcinoma
Huazhong University of Science and Technology
Phase 2 Completed